An Integrin-Targeting AAV Developed by a Novel Computational Rational Design Methodology Presents an Improved Targeting to the Skeletal Muscle and Reduced Tropism to the Liver
Conférencier(ère)s
Ai Vu Hong, chargé de recherche, Généthon & Isabelle Richard, DR1, CNRS Généthon - Muscular Dystrophy team